Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Dr. Kenneth L. Muldrew

Dr. Kenneth L. Muldrew

Associate Professor
University of Texas MD Anderson Cancer Center
USA

Biography

Dr. Kenneth L. Muldrew graduated in 1995 with an MPH (disease control) from the University of Texas Health Science Center-School of Public Health in Houston TX where he devoted significant research and study of perinatal HIV infection. In 1999 he graduated from the University of Texas Medical Branch in Galveston, TX with the degree of doctor of Medicine. Over the past 7 years, he has been a section medical director for molecular diagnostic, clinical microbiology, serology and referral testing laboratories at academic medical centers in Ohio, Mississippi, and Texas. He currently is an associate professor at Baylor College of Medicine and the University of Texas-MD Anderson Cancer Center. In addition to being a section medical director, he has been a licensed CLIA Medical director for two laboratories in the Houston area.

Research Interest

Dr. Muldrew was trained in molecular diagnostics, medical microbiology, and general anatomic and clinical pathology at the University of North Carolina-Chapel Hill, Yale University, and Vanderbilt University respectively. He is Board Certified in molecular genetic pathology, medical microbiology, and general clinical pathology by the American board of Pathology. Dr. Muldrew is an expert in the areas of general medical microbiology and the molecular diagnostics of infectious diseases. He has spent a significant portion of his time developing and validating new clinical molecular assays in infectious disease, including three clinical projects using next generation sequencing (NGS). His laboratory was one of the first in the United States to incorporate full service automation using the BD Kiestra system in the medical microbiology laboratory. He continues to focus on clinical and translational research on implementation of new diagnostic technologies and assays in medical microbiology and molecular diagnostics laboratories. In addition to test development, next generation sequencing, and laboratory management issues, He has been intimately involved in the design and implementation of new molecular and medical microbiology laboratories at Yale-New Haven hospital, the University of Toledo Medical Center, and the University of Mississippi Medical Center. He also has a special interest in teaching and training medical students and pathology residents, and fellows in the practice of clinical pathology.